-
1
-
-
0037458216
-
Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer
-
Du XLL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med. 2003;138(2):90-7.
-
(2003)
Ann Intern Med
, vol.138
, Issue.2
, pp. 90-97
-
-
Du, X.L.L.1
Key, C.R.2
Osborne, C.3
Mahnken, J.D.4
Goodwin, J.S.5
-
2
-
-
84887563411
-
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
-
Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013;15(5):R92. doi: 10.1186/bcr3493 .
-
(2013)
Breast Cancer Res
, vol.15
, Issue.5
, pp. R92
-
-
Eccles, S.A.1
Aboagye, E.O.2
Ali, S.3
Anderson, A.S.4
Armes, J.5
Berditchevski, F.6
-
3
-
-
39749097290
-
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
-
Munoz M, Henderson M, Haber M, Norris M. Role of the MRP1/ABCC1 multidrug transporter protein in cancer. IUBMB Life. 2007;59(12):752-7. doi: 10.1080/15216540701736285 .
-
(2007)
IUBMB Life
, vol.59
, Issue.12
, pp. 752-757
-
-
Munoz, M.1
Henderson, M.2
Haber, M.3
Norris, M.4
-
4
-
-
0033849017
-
MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines
-
Zalcberg J, Hu XF, Slater A, Parisot J, El-Osta S, Kantharidis P, et al. MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines. Prostate Cancer Prostatic Dis. 2000;3(2):66-75. doi: 10.1038/sj.pcan.4500394 .
-
(2000)
Prostate Cancer Prostatic Dis
, vol.3
, Issue.2
, pp. 66-75
-
-
Zalcberg, J.1
Hu, X.F.2
Slater, A.3
Parisot, J.4
El-Osta, S.5
Kantharidis, P.6
-
5
-
-
84941280357
-
Overexpression of multidrug resistance related protein (MRP) in acute myeloid leukaemia (AML) blast cells is associated with decreased intracellular daunorubicin accumulation (IDA) and predicts poor treatment outcome
-
Borg AG, Green LM, Burgess R, Yin JAL. Overexpression of multidrug resistance related protein (MRP) in acute myeloid leukaemia (AML) blast cells is associated with decreased intracellular daunorubicin accumulation (IDA) and predicts poor treatment outcome. Blood. 1996;88(10):1429.
-
(1996)
Blood
, vol.88
, Issue.10
, pp. 1429
-
-
Borg, A.G.1
Green, L.M.2
Burgess, R.3
Yin, J.A.L.4
-
6
-
-
0027095653
-
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
-
Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992;258(5088):1650-4.
-
(1992)
Science
, vol.258
, Issue.5088
, pp. 1650-1654
-
-
Cole, S.P.1
Bhardwaj, G.2
Gerlach, J.H.3
Mackie, J.E.4
Grant, C.E.5
Almquist, K.C.6
-
7
-
-
0030604554
-
Multidrug resistance protein in recurrent breast cancer
-
Nooter K, dela Riviere GB, Klijn J, Stoter G, Foekens J. Multidrug resistance protein in recurrent breast cancer. Lancet. 1997;349(9069):1885-6. doi: 10.1016/S0140-6736(05)63876-7 .
-
(1997)
Lancet
, vol.349
, Issue.9069
, pp. 1885-1886
-
-
Nooter, K.1
Riviere, G.B.2
Klijn, J.3
Stoter, G.4
Foekens, J.5
-
8
-
-
8544241727
-
The prognostic significance of expression of the multidrug resistance associated protein (MRP) in primary breast cancer
-
Nooter K, dela Riviere GB, Look MP, van Wingerden KE, Henzen Logmans SC, Scheper RJ, et al. The prognostic significance of expression of the multidrug resistance associated protein (MRP) in primary breast cancer. Br J Cancer. 1997;76(4):486-93. doi: 10.1038/Bjc.1997.414 .
-
(1997)
Br J Cancer
, vol.76
, Issue.4
, pp. 486-493
-
-
Nooter, K.1
Riviere, G.B.2
Look, M.P.3
Wingerden, K.E.4
Henzen Logmans, S.C.5
Scheper, R.J.6
-
9
-
-
0141528615
-
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy
-
Rudas M, Filipits M, Taucher S, Stranzl T, Steger GG, Jakesz R, et al. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. Breast Cancer Res Treat. 2003;81(2):149-57. doi: 10.1023/A:1025751631115 .
-
(2003)
Breast Cancer Res Treat
, vol.81
, Issue.2
, pp. 149-157
-
-
Rudas, M.1
Filipits, M.2
Taucher, S.3
Stranzl, T.4
Steger, G.G.5
Jakesz, R.6
-
10
-
-
84877043382
-
Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer
-
Kim B, Fatayer H, Hanby AM, Horgan K, Perry SL, Valleley EM, et al. Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer. PLoS One. 2013;8(5):e62766. doi: 10.1371/journal.pone.0062766 .
-
(2013)
PLoS One
, vol.8
, Issue.5
, pp. e62766
-
-
Kim, B.1
Fatayer, H.2
Hanby, A.M.3
Horgan, K.4
Perry, S.L.5
Valleley, E.M.6
-
11
-
-
0032927941
-
Cancer multidrug resistance
-
Persidis A. Cancer multidrug resistance. Nat Biotechnol. 1999;17(1):94-5. doi: 10.1038/5289 .
-
(1999)
Nat Biotechnol
, vol.17
, Issue.1
, pp. 94-95
-
-
Persidis, A.1
-
12
-
-
84855501388
-
Notch1 regulates the expression of ABCC1/MRP1 in cultured cancer cells
-
Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, et al. Notch1 regulates the expression of ABCC1/MRP1 in cultured cancer cells. PNAS USA. 2011;108(51):20778-83.
-
(2011)
PNAS USA
, vol.108
, Issue.51
, pp. 20778-20783
-
-
Cho, S.1
Lu, M.2
He, X.3
Ee, P.L.4
Bhat, U.5
Schneider, E.6
-
13
-
-
84863134360
-
Gene expression, molecular class changes, and pathway analysis after NACT for breast cancer
-
Gonzalez-Angulo AM, Iwamoto T, Liu S, Chen H, Do KA, Hortobagyi GN, et al. Gene expression, molecular class changes, and pathway analysis after NACT for breast cancer. Clin Cancer Res. 2012;18(4):1109-19. doi: 10.1158/1078-0432.CCR-11-2762 .
-
(2012)
Clin Cancer Res
, vol.18
, Issue.4
, pp. 1109-1119
-
-
Gonzalez-Angulo, A.M.1
Iwamoto, T.2
Liu, S.3
Chen, H.4
Do, K.A.5
Hortobagyi, G.N.6
-
14
-
-
3342952083
-
Notch in mammary gland development and breast cancer
-
Politi K, Feirt N, Kitajewski J. Notch in mammary gland development and breast cancer. Semin Cancer Biol. 2004;14(5):341-7. doi: 10.1016/j.semcancer.2004.04.013 .
-
(2004)
Semin Cancer Biol
, vol.14
, Issue.5
, pp. 341-347
-
-
Politi, K.1
Feirt, N.2
Kitajewski, J.3
-
15
-
-
32944470488
-
Aberrant activation of notch signaling in human breast cancer
-
Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res. 2006;66(3):1517-25. doi: 10.1158/0008-5472.CAN-05-3054 .
-
(2006)
Cancer Res
, vol.66
, Issue.3
, pp. 1517-1525
-
-
Stylianou, S.1
Clarke, R.B.2
Brennan, K.3
-
16
-
-
14244269366
-
The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer
-
Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med. 2004;14(5):779-86.
-
(2004)
Int J Mol Med
, vol.14
, Issue.5
, pp. 779-786
-
-
Parr, C.1
Watkins, G.2
Jiang, W.G.3
-
17
-
-
36248953716
-
Mammary stem cells and breast cancer--role of Notch signalling
-
Farnie G, Clarke RB. Mammary stem cells and breast cancer--role of Notch signalling. Stem Cell Rev. 2007;3(2):169-75.
-
(2007)
Stem Cell Rev
, vol.3
, Issue.2
, pp. 169-175
-
-
Farnie, G.1
Clarke, R.B.2
-
18
-
-
77949457142
-
RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer
-
Zang S, Chen F, Dai J, Guo D, Tse W, Qu X, et al. RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer. Oncol Rep. 2010;23(4):893-9.
-
(2010)
Oncol Rep
, vol.23
, Issue.4
, pp. 893-899
-
-
Zang, S.1
Chen, F.2
Dai, J.3
Guo, D.4
Tse, W.5
Qu, X.6
-
19
-
-
34748851341
-
Cell and molecular biology of Notch
-
Fiuza UM, Arias AM. Cell and molecular biology of Notch. J Endocrinol. 2007;194(3):459-74. doi: 10.1677/JOE-07-0242 .
-
(2007)
J Endocrinol
, vol.194
, Issue.3
, pp. 459-474
-
-
Fiuza, U.M.1
Arias, A.M.2
-
20
-
-
77952736684
-
Notch: Implications of endogenous inhibitors for therapy
-
Dikic I, Schmidt MH. Notch: Implications of endogenous inhibitors for therapy. Bioessays. 2010;32(6):481-7. doi: 10.1002/bies.200900140 .
-
(2010)
Bioessays
, vol.32
, Issue.6
, pp. 481-487
-
-
Dikic, I.1
Schmidt, M.H.2
-
21
-
-
40349111175
-
Therapeutic potential of gamma-secretase inhibitors and modulators
-
Imbimbo BP. Therapeutic potential of gamma-secretase inhibitors and modulators. Curr Top Med Chem. 2008;8(1):54-61.
-
(2008)
Curr Top Med Chem
, vol.8
, Issue.1
, pp. 54-61
-
-
Imbimbo, B.P.1
-
22
-
-
82255195306
-
Interacting with gamma-secretase for treating Alzheimer's disease: from inhibition to modulation
-
Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, et al. Interacting with gamma-secretase for treating Alzheimer's disease: from inhibition to modulation. Curr Med Chem. 2011;18(35):5430-47.
-
(2011)
Curr Med Chem
, vol.18
, Issue.35
, pp. 5430-5447
-
-
Panza, F.1
Frisardi, V.2
Solfrizzi, V.3
Imbimbo, B.P.4
Logroscino, G.5
Santamato, A.6
-
23
-
-
84879422834
-
Notch inhibitors for cancer treatment
-
Espinoza I, Miele L. Notch inhibitors for cancer treatment. Pharmacol Therapeut. 2013;139(2):95-110. doi: 10.1016/J.Pharmthera.2013.02.003 .
-
(2013)
Pharmacol Therapeut
, vol.139
, Issue.2
, pp. 95-110
-
-
Espinoza, I.1
Miele, L.2
-
24
-
-
84887849044
-
Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells
-
Suman S, Das TP, Damodaran C. Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. Br J Cancer. 2013;109(10):2587-96. doi: 10.1038/Bjc.2013.642 .
-
(2013)
Br J Cancer
, vol.109
, Issue.10
, pp. 2587-2596
-
-
Suman, S.1
Das, T.P.2
Damodaran, C.3
-
25
-
-
33847768973
-
Notch, Myc and breast cancer
-
Efstratiadis A, Szabolcs M, Klinakis A. Notch, Myc and breast cancer. Cell Cycle. 2007;6(4):418-29.
-
(2007)
Cell Cycle
, vol.6
, Issue.4
, pp. 418-429
-
-
Efstratiadis, A.1
Szabolcs, M.2
Klinakis, A.3
-
26
-
-
74449091897
-
Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells
-
Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW, et al. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene. 2010;29(2):201-13. doi: 10.1038/onc.2009.323 .
-
(2010)
Oncogene
, vol.29
, Issue.2
, pp. 201-213
-
-
Hao, L.1
Rizzo, P.2
Osipo, C.3
Pannuti, A.4
Wyatt, D.5
Cheung, L.W.6
-
27
-
-
33644777840
-
Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux
-
Morrow CS, Peklak-Scott C, Bishwokarma B, Kute TE, Smitherman PK, Townsend AJ. Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux. Mol Pharmacol. 2006;69(4):1499-505. doi: 10.1124/Mol.105.017988 .
-
(2006)
Mol Pharmacol
, vol.69
, Issue.4
, pp. 1499-1505
-
-
Morrow, C.S.1
Peklak-Scott, C.2
Bishwokarma, B.3
Kute, T.E.4
Smitherman, P.K.5
Townsend, A.J.6
-
28
-
-
84864384785
-
Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis
-
Mohammed ZM, Edwards J, Orange C, Mallon E, Doughty JC, McMillan DC, et al. Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis. Histopathology. 2012;61(2):283-92. doi: 10.1111/j.1365-2559.2012.04244.x .
-
(2012)
Histopathology
, vol.61
, Issue.2
, pp. 283-292
-
-
Mohammed, Z.M.1
Edwards, J.2
Orange, C.3
Mallon, E.4
Doughty, J.C.5
McMillan, D.C.6
-
29
-
-
84862247584
-
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24
-
Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID, Swain SM, et al. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 2012;30(12):1268-73. doi: 10.1200/JCO.2010.34.0141 .
-
(2012)
J Clin Oncol
, vol.30
, Issue.12
, pp. 1268-1273
-
-
Allred, D.C.1
Anderson, S.J.2
Paik, S.3
Wickerham, D.L.4
Nagtegaal, I.D.5
Swain, S.M.6
-
30
-
-
33744949267
-
C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester)
-
Morohashi Y, Kan T, Tominari Y, Fuwa H, Okamura Y, Watanabe N, et al. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). J Biol Chem. 2006;281(21):14670-6. doi: 10.1074/jbc.M513012200 .
-
(2006)
J Biol Chem
, vol.281
, Issue.21
, pp. 14670-14676
-
-
Morohashi, Y.1
Kan, T.2
Tominari, Y.3
Fuwa, H.4
Okamura, Y.5
Watanabe, N.6
-
31
-
-
77953363931
-
Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
-
Li J, Li ZN, Yu LC, Bao QL, Wu JR, Shi SB, et al. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. Lung Cancer. 2010;69(1):116-22. doi: 10.1016/j.lungcan.2009.09.013 .
-
(2010)
Lung Cancer
, vol.69
, Issue.1
, pp. 116-122
-
-
Li, J.1
Li, Z.N.2
Yu, L.C.3
Bao, Q.L.4
Wu, J.R.5
Shi, S.B.6
-
32
-
-
0033179207
-
Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia
-
Legrand O, Simonin G, Beauchamp-Nicoud A, Zittoun R, Marie JP. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood. 1999;94(3):1046-56.
-
(1999)
Blood
, vol.94
, Issue.3
, pp. 1046-1056
-
-
Legrand, O.1
Simonin, G.2
Beauchamp-Nicoud, A.3
Zittoun, R.4
Marie, J.P.5
-
33
-
-
84903446187
-
NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells
-
Liu C, Li Z, Bi L, Li K, Zhou B, Xu C, et al. NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells. Mol Cell Biochem. 2014;393(1-2):265-70. doi: 10.1007/s11010-014-2069-4 .
-
(2014)
Mol Cell Biochem
, vol.393
, Issue.1-2
, pp. 265-270
-
-
Liu, C.1
Li, Z.2
Bi, L.3
Li, K.4
Zhou, B.5
Xu, C.6
-
34
-
-
84872025630
-
Modulators of gamma-secretase activity can facilitate the toxic side-effects and pathogenesis of Alzheimer's Disease
-
Svedruzic ZM, Popovic K, Sendula-Jengic V. Modulators of gamma-secretase activity can facilitate the toxic side-effects and pathogenesis of Alzheimer's Disease. PLoS One. 2013;8(1):e50759. doi: 10.1371/journal.pone.0050759 .
-
(2013)
PLoS One
, vol.8
, Issue.1
, pp. e50759
-
-
Svedruzic, Z.M.1
Popovic, K.2
Sendula-Jengic, V.3
-
35
-
-
84864005118
-
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors
-
Krop I, Demuth T, Guthrie T, Wen PY, Mason WP, Chinnaiyan P, et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012;30(19):2307-13. doi: 10.1200/Jco.2011.39.1540 .
-
(2012)
J Clin Oncol
, vol.30
, Issue.19
, pp. 2307-2313
-
-
Krop, I.1
Demuth, T.2
Guthrie, T.3
Wen, P.Y.4
Mason, W.P.5
Chinnaiyan, P.6
-
36
-
-
84864018642
-
Phase I study of RO4929097, a gamma secretase inhibitor of notch signaling, in patients with refractory metastatic or locally advanced solid tumors
-
Tolcher AW, Messersmith WA, Mikulski SM, Papadopoulos KP, Kwak EL, Gibbon DG, et al. Phase I study of RO4929097, a gamma secretase inhibitor of notch signaling, in patients with refractory metastatic or locally advanced solid tumors. J Clin Oncol. 2012;30(19):2348-53. doi: 10.1200/Jco.2011.36.8282 .
-
(2012)
J Clin Oncol
, vol.30
, Issue.19
, pp. 2348-2353
-
-
Tolcher, A.W.1
Messersmith, W.A.2
Mikulski, S.M.3
Papadopoulos, K.P.4
Kwak, E.L.5
Gibbon, D.G.6
-
37
-
-
84859484685
-
A phase II study of RO4929097 in metastatic colorectal cancer
-
Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, et al. A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer. 2012;48(7):997-1003. doi: 10.1016/J.Ejca.2012.02.056 .
-
(2012)
Eur J Cancer
, vol.48
, Issue.7
, pp. 997-1003
-
-
Strosberg, J.R.1
Yeatman, T.2
Weber, J.3
Coppola, D.4
Schell, M.J.5
Han, G.6
-
38
-
-
84875168492
-
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors
-
Schott AF, Landis MD, Dontu G, Griffith KA, Layman RM, Krop I, et al. Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin Cancer Res. 2013;19(6):1512-24. doi: 10.1158/1078-0432.CCR-11-3326 .
-
(2013)
Clin Cancer Res
, vol.19
, Issue.6
, pp. 1512-1524
-
-
Schott, A.F.1
Landis, M.D.2
Dontu, G.3
Griffith, K.A.4
Layman, R.M.5
Krop, I.6
-
39
-
-
84877881712
-
Combining Notch inhibition with current therapies for breast cancer treatment
-
Brennan K, Clarke RB. Combining Notch inhibition with current therapies for breast cancer treatment. Ther Adv Med Oncol. 2013;5(1):17-24. doi: 10.1177/1758834012457437 .
-
(2013)
Ther Adv Med Oncol
, vol.5
, Issue.1
, pp. 17-24
-
-
Brennan, K.1
Clarke, R.B.2
|